We create high-performance biomarker assays that plug directly into drug development programs.
At Guilford Street Laboratories, we specialise in the rapid development of targeted protein, lipid and metabolite assays using advanced mass spectrometry and multi-omic technologies. Our assays are designed to move seamlessly from discovery through clinical development, generating high-quality data that drives decision-making.
Whether supporting target validation, biomarker discovery, patient stratification or clinical trial endpoints, we work closely with biotech and pharma teams to translate complex biology into robust, deployable assays.
WHAT WE DELIVER
Custom protein, lipid and metabolite biomarker assay development
Targeted LC- MS/MS assay design and optimisation
Development of multi-biomarker panels for translational research
Assays aligned with preclinical, clinical and regulatory requirements
Rapid method development for time-critical drug development programs
Our focus is simple:
building assays that deliver robust, decision-ready data to accelerate drug development programs.
By combining deep expertise in translational biomarker science with cutting-edge analytical platforms, we help partners de-risk programs, accelerate clinical insights, and unlock the value of biomarker data.
